Delivery Order SPE2D018D0006-SPE2D022F0107
- Not listed
- This federal contract award, with a total ceiling value of $5,292.66, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract is a delivery order (SPE2D325F5036) for the supply of Ryanodex, a 250mg injectable medication used for treating and preventing malignant hyperthermia in high-risk patients. The contract is a firm fixed-price arrangement with a period of performance ending on January 31,...
- This federal contract award to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer, is a delivery order from the Defense Logistics Agency Troop Support Medical. The contract is for the supply of 250mg vials of the drug Ryanodex, with a firm fixed price of $1,693.54 and a completion date of January 5, 2024. The place of performance is Westwood, New Jersey. This delivery order is part of a larger Federal Supply Schedule contract held by Eagle Pharmaceuticals through the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract, valued at $5,080.62, is for the supply of 250mg vials of the drug Ryanodex, which is used to treat and prevent malignant hyperthermia in high-risk patients. This delivery order contract is not set aside and is part of a larger Federal Supply Schedule (FSS) contract between Eagle...
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a delivery order contract valued at $10,585.32 to Eagle Pharmaceuticals, Inc. for the supply of Ryanodex 250 mg vials. The contract, awarded on August 18, 2025, with an ultimate completion date of August 21, 2025, was issued without set-aside designation under firm fixed-price terms. Performance will take place in Westwood, New Jersey. This delivery order is issued under Eagle Pharmaceuticals' existing Federal...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc. for the supply of Ryanodex, a 250mg injectable medication used for the treatment and prevention of malignant hyperthermia. The contract has a ceiling value of $10,161.24 and is a firm fixed price delivery order that runs through August 2024. Eagle Pharmaceuticals is a specialized pharmaceutical company that provides critical medications to the U.S. federal...
- The federal contract award SPE2D018D0006|SPE2D021F0173 was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Eagle Pharmaceuticals, Inc. The $87,282.92 firm fixed-price delivery order contract is for the provision of other medical supplies, specifically the 250mg injectable medication Ryanodex, used to treat and prevent malignant hyperthermia in high-risk patients. This contract does not have a set-aside designation, indicating Eagle Pharmaceuticals...
- The Defense Logistics Agency Troop Support Medical awarded Eagle Pharmaceuticals, Inc., doing business as Eagle Pharmaceuticals, a $9,748.26 firm fixed price delivery order to supply 250 mg vials of the drug Ryanodex. Performance will take place in Westwood, New Jersey over a period of one week from September 15 through September 20, 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the Department of Defense through the procurement and distribution of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Eagle Pharmaceuticals, Inc., a for-profit pharmaceutical manufacturer. The contract is for the supply of Ryanodex, a 250mg injectable medication used to treat and prevent malignant hyperthermia in high-risk patients. The contract has a ceiling value of $5,080.62 and an ultimate completion date of December 10, 2024. This contract is not associated with any set-aside...
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a firm fixed price purchase order valued at $10,585.32 to Eagle Pharmaceuticals, Inc. for Dantrolene Sodium F, with performance expected to conclude by September 19, 2025. This contract is designated as a Total Small Business set-aside and was awarded on September 4, 2025, with work to be performed in Westwood, New Jersey. Eagle Pharmaceuticals, a specialized pharmaceutical manufacturer headquartered in...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,082.24 firm fixed-price delivery order is for the supply of RYANODEX 250 MG VIALS, a critical pharmaceutical product. The award is under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2D018D0006Indefinite Delivery Contract
- SPE2D018D0006-SPE2D022F0107Delivery Order
The U.S. Defense Logistics Agency Troop Support Medical awarded a delivery order contract to Eagle Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical products, to provide the drug Ryanodex (250mg vials). The contract has a firm fixed price of $92,838.80 and a period of performance through April 6, 2023. This award is part of Eagle Pharmaceuticals' existing Federal Supply Schedule contract with the Department of Veterans Affairs Veterans Health Administration, which has a potential value of $30,890,560 over five years to supply drugs, pharmaceuticals, and hematology-related products to VA medical facilities in VISN 12 (New Jersey, Pennsylvania, and Delaware). The contract has no set-aside designation, and no major subcontractors are involved. The award supports the DLA Troop Support Medical's mission of distributing pharmaceuticals for Department of Defense medical readiness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $92.8k | 2/25/22 |